April 11, 2013 — A new oral diabetes drug is expected to arrive on pharmacy shelves in the U.S. this week. Many people predict that Invokana (canagliflozin), approved by the FDA in March, will be a brisk seller. That's partly because it treats type 2
(April 8, 2013) – On the heels of the recent HDR TMK merger, HDR TMK has been selected to design its first science + technology project in Europe?the Center of Integrated Diabetes Research at the Helmholtz Center in Munich.